Breaking Finance News

Inogen (NYSE:INGN) stock price target increased to $108.00, issued a research note today by Needham

In a report released on Thursday June 08, 2017 Needham increased the stock price target of Inogen (NYSE:INGN) from $96.00 to $108.00 reporting a possible upside of 0.15%.

Previously on 05/11/2017, Needham Company LLC released a statement about Inogen (NYSE:INGN) increased the target price from $0.00 to $96.00. At the time, this indicated a possible upside of 0.15%.

Just yesterday Inogen (NYSE:INGN) traded -0.03% lower at $93.96. Inogen’s 50-day moving average is $98.06 and its 200-day moving average is $90.62. The last stock price is up 3.36% from the 200-day moving average, compared to the Standard & Poor's 500 Index which has increased 0.03% over the same time period. 104,154 shares of INGN traded hands, down from an average trading volume of 178,860

Recent Performance Chart

Inogen (NYSE:INGN)

Inogen has 52 week low of $50.24 and a 52 week high of $105.35 with a PE ratio of 81.30 and has a market capitalization of $0.

In addition to Needham reporting its stock price target, a total of 5 brokerages have issued a research note on the company. The average stock price target is $54.20 with 0 brokerages rating the stock a strong buy, 0 brokerages rating the stock a buy, 0 brokerages rating the stock a hold, 0 brokerages rating the stock a underperform, and finally 0 brokerages rating the stock a sell.

Brief Synopsis On Inogen (NYSE:INGN)

Inogen, Inc. is a medical technology company. The Company develops, manufactures and markets portable oxygen concentrators used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions. The Company's Inogen One systems concentrate the air around the patient to offer a single source of supplemental oxygen anytime, anywhere with a portable device. Its three portable product offerings, the Inogen One G4, Inogen One G3 and Inogen One G2, at approximately 2.8, 4.8 and 7.0 pounds with a single battery, respectively. Its Inogen One G4, Inogen One G3 and Inogen One G2 are sub-3, sub-5 and sub-10 pound portable oxygen concentrators, respectively. All of its Inogen One systems are equipped with Intelligent Delivery Technology. The Inogen At Home stationary oxygen concentrator allows it to access the non-ambulatory oxygen patient market and serves as a backup to its Inogen One system for ambulatory patients on its rental service.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with MarketBeat.com's FREE daily email newsletter.

Leave a Reply

Your email address will not be published. Required fields are marked *